Sudeep Pharma MD, chairman, board of directors and AGM

Mutual fund votes, meeting of 4 Aug 2026, 4 fund houses so far (houses' deadline to file 15 Oct 2026)

Each resolution counts the houses whose vote was matched to it; the rest are listed last.

• To receive, consider and adopt the Audited Standalone and Consolidated Financial Statements of the Company for the Financial Year ended 31st March, 2026 together with the Reports of the Board of Directors and Auditors thereonMoreLess

  4 for0 against
• Re appointment of Mr Ajay Shrirang Kandelkar (DIN: 10773491) as a director, who retires by rotation and being eligible, offers himself for re appointment.

  4 for0 against
• To declare dividend on equity shares for the financial year ended 31st March 2026

  4 for0 against
• To Appoint Mr. Hemang Mehta, a proprietor of H. M. Mehta and Associates, Peer reviewed Practicing Company Secretary, as Secretarial Auditor of the Company for a term of 5 (Five) consecutive years and fix their remuneration.MoreLess

  4 for0 against
• Appointment of Mr. Milin Mehta as a Director (Non Executive and Non Independent).

  4 for0 against
• To ratify Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, PGIM India Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.
  • Edelweiss Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Exercise Price not disclosed as required under law. Governance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the NRC to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.

  0 for3 against
• To approve the grant of employee stock options to the eligible employees of the subsidiary company(ies) of the Company under Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, PGIM India Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting.
  • Edelweiss Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Interlinked with resolution #7.

  0 for3 against
• To approve the grant of employee stock options to the eligible employees of the group company including associate company(ies) of the Company under Sudeep Pharma Employee Stock Option Scheme 2025

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, PGIM India Mutual Fund

  • Angel One Mutual FundGovernance and Transparency Concern: The Scheme provides discretion to the Committee to alter / vary Exercise Period at the employee level; the Scheme provides a broad range of Vesting period, which may lead to exercise of excessive discretion by the Board or the Compensation Committee and does not enable shareholders to take an informed decision; further, the Scheme provides discretion to the Nomination & Remuneration Committee to alter the vesting period at its discretion and hence indirectly granting them discretion to accelerate vesting. and Scheme proposed to be extended to Associate Companies without any affirmation on cost reimbursement.
  • Edelweiss Mutual Fund, PGIM India Mutual FundNon-Compliant with SEBI (SBEB & SE) Regulations 2021: Interlinked with resolution #7. Governance Concern: Scheme proposed to be extended to Associate Companies without any affirmation on cost reimbursement.

  1 for3 against
• To Change the Remuneration of Mr. Ajay Shrirang Kandelkar (DIN: 10773491) as Whole Time Director w.e.f. 1st April 2026

  4 for0 against
• To adopt new set of Articles of Association (AOA)

  ›Against Angel One Mutual Fund, Edelweiss Mutual Fund, PGIM India Mutual Fund

  • Angel One Mutual FundGovernance & Transparency Concern: Proposed AoA not disclosed / cannot be located.
  • Edelweiss Mutual Fund, PGIM India Mutual FundCompliant with law. Governance & Transparency Concern: Proposed AoA not disclosed / cannot be located.

  1 for3 against

The board is made up as the listing rules require

Yes

The board has a regular chairperson

Yes

The company has a risk management committee

Yes

The chair is related to the managing director

No

The filing has a part on fines and penalties

No

The filing has a part on tax disputes

No

There was a cyber security incident in the quarter

No

The company's own answers in its filing.